Astellas Pharma, Inc.

Industry

  • Pharmaceuticals
    • Vaccines
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • Advanced Cell Technology
  • Agensys
  • Audentes Therapeutics
  • Fujisawa
  • Ganymed Pharmaceuticals
  • Iota Biosciences
  • Iveric Bio
  • Mytogen
  • Nanna Therapeutics
  • Perseid Therapeutics
  • Potenza Therapeutics
  • Ocata Therapeutics
  • OSI Pharmaceuticals
  • Yamanouchi Pharmaceutical
  • Ogeda
  • Mitobridge
  • Mitokyne
  • Quethera
  • Universal Cells
  • Xyphos Biosciences
  • Astellas Pharma Malaysia
  • Astellas Pharma Singapore
  • Astellas Institute for Regenerative Medicine
  • Propella
See more in Biomedtracker

Latest on Astellas Pharma, Inc.

Scrip

Corcept’s Relacorilant Shows Benefit In Ovarian Cancer, Expanding Pipeline Opportunity

 
• By Jessica Merrill

Corcept Therapeutics’ cortisol modulator relacorilant improved progression-free survival (PFS) and overall survival (OS) in a Phase III trial in patients with platinum-resistant ovarian cancer, paving

Scrip

Deal Watch: Amgen, CytomX Pull Back On Part Of T-Cell Engager Collaboration

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. CytomX, Amgen Decision Follows January

Scrip

Bayer Execs Roth And Eckhardt On Current And Future Pharma Growth

 
• By Mandy Jackson

Bayer has asked investors for patience as the conglomerate works its way through various challenges across its pharmaceuticals, crop science and consumer health businesses, and in 2024 pharma showed t

Scrip

Asia Deal Watch: AstraZeneca Buys FibroGen’s Chinese Subsidiary

 
• By Joseph Haas, Vibha Ravi, Lisa Takagi, Dexter Jie Yan, and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Deal Brings AstraZeneca Greater C